Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.71M Sell
7,473
-4,953
-40% -$1.7M 0.08% 241
2026
Q1
$4.18M Buy
12,426
+3,675
+42% +$1.31M 0.11% 156
2025
Q4
$2.86M Buy
8,751
+4,940
+130% +$1.57M 0.12% 171
2025
Q3
$1.08M Buy
3,811
+657
+21% +$191K 0.04% 355
2025
Q2
$899K Buy
3,154
+782
+33% +$222K 0.04% 344
2025
Q1
$739K Buy
+2,372
New +$700K 0.03% 338

Other funds holding AMGN

VestGen Advisors's AMGN Position: Q2 2026 in Review

VestGen Advisors reduced its Amgen (AMGN) stake by 40% in Q2 2026, selling an estimated $1.7M and leaving 7,473 shares worth $2.71M. The position accounts for 0.08% of the portfolio, ranked #241.

VestGen Advisors first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.18M in Q1 2026. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • VestGen Advisors held 7,473 shares of Amgen worth $2.71M as of Q2 2026.
  • VestGen Advisors sold 4,953 Amgen shares in Q2 2026, an estimated $1.7M.
  • Amgen made up 0.08% of VestGen Advisors's portfolio in Q2 2026, its #241 holding.
  • VestGen Advisors first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • VestGen Advisors's Amgen position peaked at $4.18M in Q1 2026.
  • 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.